SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 260 participants.
Also called NCT07631780
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 260 participants
- Registry
-
NCT07631780
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Kazakhstan
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07631780. Randomized; no masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
- Acronym
- SURE-HF
- Condition
- Worsening Heart Failure
- Condition
- Congestion
- Condition
- Heart Failure
- Intervention (Drug)
- Furosemide
- Intervention (Device)
- Horiba LAQUAtwin B-722
- Lead sponsor
- Nurgul Ablakimova
- Collaborator
- I.M. Sechenov First Moscow State Medical University
Record details
- Record id
cardio:ct-nct07631780- Content hash
0ff945c0c59acc9a0d7ac594f3b4c752c28597d0c80ca555f54da86a0df920af